Hemangiosarcoma Cells Promote Conserved Host-Derived Hematopoietic Expansion.


Journal

Cancer research communications
ISSN: 2767-9764
Titre abrégé: Cancer Res Commun
Pays: United States
ID NLM: 9918281580506676

Informations de publication

Date de publication:
16 May 2024
Historique:
accepted: 10 05 2024
received: 12 10 2023
revised: 29 02 2024
medline: 17 5 2024
pubmed: 17 5 2024
entrez: 17 5 2024
Statut: aheadofprint

Résumé

Hemangiosarcoma and angiosarcoma are soft-tissue sarcomas of blood vessel-forming cells in dogs and humans, respectively. These vasoformative sarcomas are aggressive and highly metastatic, with disorganized, irregular blood-filled vascular spaces. Our objective was to define molecular programs which support the niche that enables progression of canine hemangiosarcoma and human angiosarcoma. Dog-in-mouse hemangiosarcoma xenografts recapitulated the vasoformative and highly angiogenic morphology and molecular characteristics of primary tumors. Blood vessels in the tumors were complex and disorganized, and they were lined by both donor and host cells. In a series of xenografts, we observed that the transplanted hemangiosarcoma cells created exuberant myeloid hyperplasia and gave rise to lymphoproliferative tumors of mouse origin. Our functional analyses indicate that hemangiosarcoma cells generate a microenvironment that supports expansion and differentiation of hematopoietic progenitor populations. Furthermore, gene expression profiling data revealed hemangiosarcoma cells expressed a repertoire of hematopoietic cytokines capable of regulating the surrounding stromal cells. We conclude that canine hemangiosarcomas, and possibly human angiosarcomas, maintain molecular properties that provide hematopoietic support and facilitate stromal reactions, suggesting their potential involvement in promoting the growth of hematopoietic tumors.

Identifiants

pubmed: 38757809
pii: 745407
doi: 10.1158/2767-9764.CRC-23-0441
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Jong Hyuk Kim (JH)

University of Florida, Gainesville, FL, United States.

Ashley J Schulte (AJ)

University of Minnesota, St Paul, MN, United States.

Aaron L Sarver (AL)

University of Minnesota, Minneapolis, United States.

Donghee Lee (D)

University of Florida, Gainesville, FL, United States.

Mathew G Angelos (MG)

Hospital of the University of Pennsylvania, United States.

Aric M Frantz (AM)

University of Minnesota, MN, United States.

Colleen L Forster (CL)

University of Minnesota, Minneapolis, MN, United States.

Timothy D O'Brien (TD)

University of Minnesota, Saint Paul, MN, United States.

Ingrid Cornax (I)

University of Minnesota, United States.

M Gerard O'Sullivan (MG)

University of Minnesota, St. Paul, Minnesota, United States.

Nuojin Cheng (N)

University of Colorado Boulder, United States.

Mitzi Lewellen (M)

University of Minnesota, Minneapolis, MN, United States.

LeAnn Oseth (L)

University of Minnesota, Minneapolis, MN, United States.

Sunil Kumar (S)

University of Minnesota, United States.

Susan Bullman (S)

Fred Hutchinson Cancer Center, Seattle, WA, United States.

Chandra Sekhar Pedamallu (CS)

Excelra, Hyderabad, Telangana, India.

Sagar M Goyal (SM)

University of Minnesota, St Paul, MN, United States.

Matthew Meyerson (M)

Dana-Farber Cancer Institute, Boston, MA, United States.

Troy C Lund (TC)

University of Minnesota Medical Center, Fairview, Minneapolis, United States.

Matthew Breen (M)

North Carolina State University, Raleigh, United States.

Kerstin Lindblad-Toh (K)

Broad Institute of MIT and Harvard, Cambridge (USA) - Uppsala (Sweden), United States.

Erin B Dickerson (EB)

University of Minnesota, Saint Paul, MN, United States.

Dan S Kaufman (DS)

UC- San Diego, La Jolla, CA, United States.

Jaime F Modiano (JF)

University of Minnesota, Minneapolis, MN, United States.

Classifications MeSH